Company Filing History:
Years Active: 2013
Title: Izabela Sibliska: Innovator in Vitamin D Analog Research
Introduction
Izabela Sibliska is a prominent inventor based in Warsaw, Poland. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of vitamin D analogs. Her innovative work focuses on compounds that have potential applications in cancer treatment.
Latest Patents
Izabela holds a patent for "2-methylene-19-nor-vitamin D analogs and their uses." This invention discloses specific analogs, including (20S)-25-hydroxy-2-methylene-19-nor-vitamin D and (20R)-25-hydroxy-2-methylene-19-nor-vitamin D. These compounds exhibit relatively high binding activity and show promise in arresting the proliferation of undifferentiated cells. They also induce differentiation to monocytes, indicating their potential as anti-cancer agents, particularly for treating or preventing osteosarcoma, leukemia, colon cancer, breast cancer, skin cancer, and prostate cancer. Although these compounds have relatively low calcemic activities, they may also be useful in treating bone diseases due to their ability to act as prodrugs in vivo.
Career Highlights
Izabela is associated with the Wisconsin Alumni Research Foundation, where she continues her research and development efforts. Her work has garnered attention for its potential impact on cancer therapies and bone disease treatments.
Collaborations
Izabela has collaborated with notable researchers in her field, including Hector Floyd Deluca and Lori A Plum. These collaborations have further enhanced her research and contributed to the advancement of vitamin D analog studies.
Conclusion
Izabela Sibliska's innovative research in vitamin D analogs showcases her commitment to advancing medical science. Her contributions have the potential to significantly impact cancer treatment and bone health.